Home
Conditions
Congenital Abnormalities

Clinical trial condition

Congenital Abnormalities

Explore clinical trials studying Congenital Abnormalities. Study availability and eligibility vary by location and protocol.

581 public trials 52 recruiting studies

Refine in advanced search Browse all conditions

Congenital Abnormalities trial results

Completed

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

NCT00296023

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +64 more
Locations: Alta Bates Comprehensive Cancer Center Berkeley, California, United States

UCSF Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

NCT00787761

Conditions: Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
Locations: Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States

View Trial Details

Completed

A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide

NCT00005793

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00110045

Conditions: Adnexal Diseases, Amyloidosis, Ataxia, +137 more
Locations: CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium

Centre Hospitalier Universitaire Henri Mondor Créteil, France

Hopital Edouard Herriot - Lyon Lyon, France

Hopital Saint-Louis Paris, France

View all 13 locations

View Trial Details

Completed

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

NCT00666211

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
Locations: Jennie Stuart Medical Center Hopkinsville, Kentucky, United States

Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States

Erlanger Health System Chattanooga, Tennessee, United States

Tennessee Plateau Oncology Crossville, Tennessee, United States

View Trial Details

Completed

Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia

NCT00052299

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: A. oe. Krankenhaus der Barmherzigen Schwestern Kinderabteilung Linz, Austria

Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria

AZ Sint-Jan Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

View all 55 locations

View Trial Details

Completed

Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome

NCT00077116

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations: AZ Sint-Jan Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

Cliniques Universitaires Saint-Luc Brussels, Belgium

H. Hartziekenhuis - Roeselaere. Roeselare, Belgium

View Trial Details

Completed

Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004896

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +25 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004899

Conditions: Bone Marrow Diseases, Chronic Disease, Congenital Abnormalities, +20 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

NCT00237627

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +99 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Congenital Abnormalities

Congenital Abnormalities trial results

Related conditions